{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:26:29Z","timestamp":1768703189154,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jaad.2018.07.040","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T12:53:56Z","timestamp":1533300836000},"page":"485-492.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States"],"prefix":"10.1016","volume":"80","author":[{"given":"Fan Di","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart S.","family":"Ferket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy A.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jaad.2018.07.040_bib1","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jaad.2018.07.040_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2018.07.040_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and S\u00e9zary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"23","key":"10.1016\/j.jaad.2018.07.040_bib4","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"issue":"31","key":"10.1016\/j.jaad.2018.07.040_bib5","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.07.040_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008946","article-title":"Interventions for mycosis fungoides","volume":"9","author":"Weberschock","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jaad.2018.07.040_bib9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/bjd.12954","article-title":"Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review","volume":"170","author":"Wu","year":"2014","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2018.07.040_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archderm.134.8.949","article-title":"Topical corticosteroids for mycosis fungoides: experience in 79 patients","volume":"134","author":"Zackheim","year":"1998","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.139.2.165","article-title":"Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamadermatol.541","article-title":"Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides","volume":"149","author":"Lessin","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.07.040_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0190-9622(03)01475-0","article-title":"Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial","volume":"49","author":"Heald","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.07.040_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.138.3.325","article-title":"Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma","volume":"138","author":"Breneman","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.07.040_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.141.3.305","article-title":"Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy","volume":"141","author":"Querfeld","year":"2005","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1468-3083.2009.03500.x","article-title":"Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides","volume":"24","author":"Ponte","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mjd.2003.80","article-title":"Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study","volume":"48","author":"Diederen","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0781.2005.00183.x","article-title":"Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right\u2013left comparative study","volume":"21","author":"El-Mofty","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1016\/j.jaad.2018.07.040_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2340\/00015555-0283","article-title":"Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study","volume":"87","author":"Ahmad","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0190-9622(93)70155-M","article-title":"Home UV phototherapy of early mycosis fungoides: long-term follow-up observations in thirty-one patients","volume":"29","author":"Resnik","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mjd.2002.120911","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides","volume":"47","author":"Gathers","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000161114","article-title":"Treatment of early stages of mycosis fungoides with narrowband ultraviolet B","volume":"218","author":"Dereure","year":"2009","journal-title":"Dermatology"},{"issue":"7","key":"10.1016\/j.jaad.2018.07.040_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1468-3083.2006.01635.x","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes","volume":"20","author":"G\u00f6kdemir","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2018.07.040_bib25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archderm.135.11.1377","article-title":"Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides","volume":"135","author":"Hofer","year":"1999","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archderm.136.6.748","article-title":"Narrowband TL-01 phototherapy for patch-stage mycosis fungoides","volume":"136","author":"Clark","year":"2000","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2018.07.040_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2006.01557.x","article-title":"UVB in the management of early stage mycosis fungoides","volume":"20","author":"Pavlotsky","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2005.03.012","article-title":"Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides","volume":"53","author":"Boztepe","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2230.2005.01840.x","article-title":"Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients","volume":"30","author":"Ghodsi","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1468-3083.2005.01317.x","article-title":"Efficacy of narrowband UVB phototherapy in early stage of mycosis fungoides","volume":"20","author":"Kural","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2018.07.040_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archderm.1992.01680170063007","article-title":"Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma","volume":"128","author":"Ramsay","year":"1992","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0781.2007.00314.x","article-title":"Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients","volume":"23","author":"Brazzelli","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"10.1016\/j.jaad.2018.07.040_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2012.05.034","article-title":"Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma","volume":"85","author":"Thomas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.jaad.2018.07.040_bib34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0360-3016(83)90321-8","article-title":"Palliative radiation treatment of cutaneous mycosis fungoides\u2014a dose response","volume":"9","author":"Cotter","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(00)90140-3","article-title":"Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant","volume":"42","author":"Heald","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B-and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jaad.2018.07.040_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09546630802516571","article-title":"Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients","volume":"20","author":"Piccinno","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaad.2011.04.004","article-title":"The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study","volume":"66","author":"Stern","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.040_bib42","series-title":"Decision Making in Health and Medicine with CD-ROM: Integrating Evidence and Values","author":"Hunink","year":"2001"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib45","doi-asserted-by":"crossref","first-page":"e8933","DOI":"10.1371\/journal.pone.0008933","article-title":"The average body surface area of adult cancer patients in the UK: a multicentre retrospective study","volume":"5","author":"Sacco","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaad.2018.07.040_bib46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2230.1991.tb01232.x","article-title":"The finger-tip unit\u2014a new practical measure","volume":"16","author":"Long","year":"1991","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.det.2015.05.006","article-title":"Radiation therapy for cutaneous T-cell lymphomas","volume":"33","author":"Tandberg","year":"2015","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2340\/0001555557341343","article-title":"Squamous cell carcinoma appearing in x-ray-treated mycosis fungoides","volume":"57","author":"Volden","year":"1977","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2018.07.040_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.07.040_bib52","doi-asserted-by":"crossref","first-page":"223.e1","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): part II. Prognosis, management, and future directions","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.07.040_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CCID.S27482","article-title":"Emerging treatment options for early mycosis fungoides","volume":"6","author":"Fernandez-Guarino","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.07.040_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1203475415626686","article-title":"Tazarotene 0.1% cream as monotherapy for early-stage cutaneous T-cell lymphoma","volume":"20","author":"Besner Morin","year":"2016","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.jaad.2018.07.040_bib55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2003.09.005","article-title":"Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study","volume":"50","author":"Apisarnthanarax","year":"2004","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218323429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218323429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:49Z","timestamp":1759272589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218323429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0190962218323429"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.07.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}